BlackRock, Inc. 13D and 13G filings for Axsome Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 5:25 pm Purchase |
2023-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
3,239,746 6.800% |
736,769 (+29.44%) |
Filing |
| 2023-02-01 4:54 pm Purchase |
2022-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,502,977 5.800% |
393,355 (+18.65%) |
Filing |
| 2022-02-03 4:41 pm Sale |
2021-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,109,622 5.600% |
-170,144 (-7.46%) |
Filing |
| 2021-01-28 5:55 pm Purchase |
2020-12-31 | 13G | Axsome Therapeutics, Inc. AXSM |
BlackRock Inc. BLK |
2,279,766 6.100% |
119,520 (+5.53%) |
Filing |